It is well known that breastmilk is enriched with nutrients, bioactive molecules, antibodies, and beneficial microbes, all of which are immunoprotective and essential to the growth and development of the child. However, HCPs must be vigilant in prescribing pharmacotherapy to lactating mothers because not all drugs are safe and tolerable for infants, especially pre-term infants. Drug metabolism and excretion are not efficient in premature infants.
Additionally, in infants with prior in-utero exposure to a drug, further exposure via breastmilk can increase the existing drug concentration. Here’s an interesting question for you on the clinical considerations for lactating mothers. Click to answer!
